Caricamento...

Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis

PDE9 inhibitors have been studied as therapeutics for treatment of cardiovascular diseases, diabetes, and neurodegenerative disorders. To illustrate the inhibitor selectivity, the crystal structures of the PDE9A catalytic domain in complex with the enantiomers of PDE9 inhibitor 1-(2-chlorophenyl)-6-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wang, Huanchen, Luo, Xuan, Ye, Mengchun, Hou, Jing, Robinson, Howard, Ke, Hengming
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2831206/
https://ncbi.nlm.nih.gov/pubmed/20121115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm901519f
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !